Clinical evaluation of cinnarizine in hyperlipaemic patients.
D000368:Aged; D002784:Cholesterol / Q000097:blood; D002936:Cinnarizine / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D006949:Hyperlipidemias / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood
D008055:Lipids; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D010879:Piperazines; D014280:Triglycerides; D002936:Cinnarizine; D002784:Cholesterol